Literature DB >> 22940425

Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation.

Jean Ndjomou1, Rajesh Kolli, Sourav Mukherjee, William R Shadrick, Alicia M Hanson, Noreena L Sweeney, Diana Bartczak, Kelin Li, Kevin J Frankowski, Frank J Schoenen, David N Frick.   

Abstract

The hepatitis C virus (HCV) multifunctional nonstructural protein 3 (NS3) is a protease that cleaves viral and host proteins and a helicase that separates DNA and RNA structures in reactions fueled by ATP hydrolysis. Li et al. (2012) recently synthesized a series of new NS3 helicase inhibitors from the benzothiazole dimer component of the fluorescent yellow dye primuline. This study further characterizes a subset of these primuline derivatives with respect to their specificity, mechanism of action, and effect on cells harboring HCV subgenomic replicons. All compounds inhibited DNA and RNA unwinding catalyzed by NS3 from different HCV genotypes, but only some inhibited the NS3 protease function, and few had any effect on HCV NS3 catalyzed ATP hydrolysis. A different subset contained potent inhibitors of RNA stimulated ATP hydrolysis catalyzed by the related NS3 protein from Dengue virus. In assays monitoring intrinsic protein fluorescence in the absence of nucleic acids, the compounds cooperatively bound NS3 with K(d)s that reflect their potency in assays. The fluorescent properties of the primuline derivatives both in vitro and in cells are also described. The primuline derivative that was the most active against subgenomic replicons in cells caused a 14-fold drop in HCV RNA levels (IC(50)=5±2μM). In cells, the most effective primuline derivative did not inhibit the cellular activity of NS3 protease but disrupted HCV replicase structures.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940425      PMCID: PMC3571690          DOI: 10.1016/j.antiviral.2012.08.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  43 in total

1.  A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target.

Authors:  Nikolaus Schiering; Allan D'Arcy; Frederic Villard; Oliver Simic; Marion Kamke; Gaby Monnet; Ulrich Hassiepen; Dmitri I Svergun; Ruth Pulfer; Jörg Eder; Prakash Raman; Ursula Bodendorf
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  R Guntern; C Bouras; P R Hof; P G Vallet
Journal:  Experientia       Date:  1992-01-15

3.  Helicase from hepatitis C virus, energetics of DNA binding.

Authors:  Mikhail K Levin; Smita S Patel
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

4.  A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

Authors:  A Y Howe; R Chase; S S Taremi; C Risano; B Beyer; B Malcolm; J Y Lau
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

5.  Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase.

Authors:  Alicia M Hanson; John J Hernandez; William R Shadrick; David N Frick
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

6.  Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase.

Authors:  Angela M I Lam; David N Frick
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase.

Authors:  Rudolf K F Beran; Brett D Lindenbach; Anna Marie Pyle
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

8.  Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.

Authors:  Craig A Belon; Yoji D High; Tse-I Lin; Frederik Pauwels; David N Frick
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

9.  The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication.

Authors:  Brett D Lindenbach; Béla M Prágai; Roland Montserret; Rudolf K F Beran; Anna M Pyle; François Penin; Charles M Rice
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

10.  Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.

Authors:  Sourav Mukherjee; Alicia M Hanson; William R Shadrick; Jean Ndjomou; Noreena L Sweeney; John J Hernandez; Diana Bartczak; Kelin Li; Kevin J Frankowski; Julie A Heck; Leggy A Arnold; Frank J Schoenen; David N Frick
Journal:  Nucleic Acids Res       Date:  2012-06-27       Impact factor: 16.971

View more
  9 in total

1.  Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.

Authors:  David R McGivern; Takahiro Masaki; William Lovell; Chris Hamlett; Susanne Saalau-Bethell; Brent Graham
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

2.  Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy.

Authors:  Jean Ndjomou; M Josie Corby; Noreena L Sweeney; Alicia M Hanson; Cihan Aydin; Akbar Ali; Celia A Schiffer; Kelin Li; Kevin J Frankowski; Frank J Schoenen; David N Frick
Journal:  ACS Chem Biol       Date:  2015-05-22       Impact factor: 5.100

3.  Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase.

Authors:  Noreena L Sweeney; Alicia M Hanson; Sourav Mukherjee; Jean Ndjomou; Brian J Geiss; J Jordan Steel; Kevin J Frankowski; Kelin Li; Frank J Schoenen; David N Frick
Journal:  ACS Infect Dis       Date:  2015-03-13       Impact factor: 5.084

4.  Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis.

Authors:  Noreena L Sweeney; William R Shadrick; Sourav Mukherjee; Kelin Li; Kevin J Frankowski; Frank J Schoenen; David N Frick
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

5.  Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP.

Authors:  William R Shadrick; Sourav Mukherjee; Alicia M Hanson; Noreena L Sweeney; David N Frick
Journal:  Biochemistry       Date:  2013-08-26       Impact factor: 3.162

6.  Identification and biochemical characterization of halisulfate 3 and suvanine as novel inhibitors of hepatitis C virus NS3 helicase from a marine sponge.

Authors:  Atsushi Furuta; Kazi Abdus Salam; Idam Hermawan; Nobuyoshi Akimitsu; Junichi Tanaka; Hidenori Tani; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Masayoshi Tsubuki; Poh Wee Peng; Youichi Suzuki; Naoki Yamamoto; Yuji Sekiguchi; Satoshi Tsuneda; Naohiro Noda
Journal:  Mar Drugs       Date:  2014-01-21       Impact factor: 5.118

7.  Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.

Authors:  Sourav Mukherjee; Warren S Weiner; Chad E Schroeder; Denise S Simpson; Alicia M Hanson; Noreena L Sweeney; Rachel K Marvin; Jean Ndjomou; Rajesh Kolli; Dragan Isailovic; Frank J Schoenen; David N Frick
Journal:  ACS Chem Biol       Date:  2014-08-15       Impact factor: 5.100

Review 8.  Discovering new medicines targeting helicases: challenges and recent progress.

Authors:  William R Shadrick; Jean Ndjomou; Rajesh Kolli; Sourav Mukherjee; Alicia M Hanson; David N Frick
Journal:  J Biomol Screen       Date:  2013-03-27

9.  Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient.

Authors:  Paola J S Provazzi; Sourav Mukherjee; Alicia M Hanson; Mauricio L Nogueira; Bruno M Carneiro; David N Frick; Paula Rahal
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.